Cargando…

Pancreatic Safety of Sitagliptin in the TECOS Study

OBJECTIVE: We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i). RESEARCH DESIGN AND METHODS: In the Trial Evaluating Cardiovascular Outcomes w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buse, John B., Bethel, M. Angelyn, Green, Jennifer B., Stevens, Susanna R., Lokhnygina, Yuliya, Aschner, Pablo, Grado, Carlos Raffo, Tankova, Tsvetalina, Wainstein, Julio, Josse, Robert, Lachin, John M., Engel, Samuel S., Patel, Keyur, Peterson, Eric D., Holman, Rury R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864139/ https://www.ncbi.nlm.nih.gov/pubmed/27630212 http://dx.doi.org/10.2337/dc15-2780

Ejemplares similares

Progression of glucose‐lowering diabetes therapy in TECOS
por: Bethel, M. Angelyn, et al.
Publicado: (2018)

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
por: Nauck, Michael A., et al.
Publicado: (2019)

Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease
por: Bethel, M. Angelyn, et al.
Publicado: (2023)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014)

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
por: Nauck, Michael, et al.
Publicado: (2014)

Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2017)

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
por: Peters, Anne L., et al.
Publicado: (2015)

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study
por: Takeshita, Yumie, et al.
Publicado: (2015)

Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial
por: Matsushima, Yukiko, et al.
Publicado: (2016)

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
por: Coleman, Ruth L., et al.
Publicado: (2019)

Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
por: Ghosal, Samit, et al.
Publicado: (2016)

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2008)

Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
por: Scirica, Benjamin M., et al.
Publicado: (2022)

Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial
por: Mentz, Robert J., et al.
Publicado: (2018)

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
por: Davis, Timothy M. E., et al.
Publicado: (2022)

The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis
por: Dimova, Rumyana, et al.
Publicado: (2015)

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial
por: Kraus, William E, et al.
Publicado: (2018)

Psychosocial Research and Care in Diabetes: Altering Lives by Understanding Attitudes
por: Weinger, Katie, et al.
Publicado: (2016)

Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes
por: de Groot, Mary, et al.
Publicado: (2016)

Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association
por: Young-Hyman, Deborah, et al.
Publicado: (2016)

Pilot randomised controlled trial of focused narrative intervention for moderate to severe depression in palliative care patients: DISCERN trial
por: Lloyd-Williams, Mari, et al.
Publicado: (2017)

Patients’ and caregivers’ needs, experiences, preferences and research priorities in spiritual care: A focus group study across nine countries
por: Selman, Lucy Ellen, et al.
Publicado: (2017)

Development and evaluation of the Dignity Talk question framework for palliative patients and their families: A mixed-methods study
por: Guo, Qiaohong, et al.
Publicado: (2017)

FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES
por: Neiman, Nicole, et al.
Publicado: (2022)

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2018)

Positive reinforcement by general practitioners is associated with greater physical activity in adults with type 2 diabetes
por: Geerling, Ralph, et al.
Publicado: (2019)

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
por: Siraj, Elias S., et al.
Publicado: (2015)

Multifaceted Determinants for Achieving Glycemic Control: The International Diabetes Management Practice Study (IDMPS)
por: Chan, Juliana C.N., et al.
Publicado: (2009)

High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study
por: Aschner, Pablo, et al.
Publicado: (2021)

Self-compassion, sleep quality and psychological well-being in type 2 diabetes: a cross-sectional study
por: Gunn, Sarah, et al.
Publicado: (2022)

Responses to the Strengths and Difficulties Questionnaire predict HbA1c trajectories in children and adolescents with type 1 diabetes: a population-based study
por: Marks, Kevin P, et al.
Publicado: (2023)

Patients’ perspectives on social and goal-based comparisons regarding their diabetes health status
por: Martinez, William, et al.
Publicado: (2018)

Amount and intensity effects of exercise training alone versus a combined diet and exercise lifestyle intervention on health-related quality of life in the STRRIDE-PD randomized trial
por: Collins, Katherine A, et al.
Publicado: (2022)

A Decade of Tweets: Visualizing Racial Sentiments Towards Minoritized Groups in the United States Between 2011 and 2021
por: Nguyen, Thu T., et al.
Publicado: (2023)

Medicaid Waiver Personal Care Services: Results of a Statewide Survey
por: Glass, Anne P., et al.
Publicado: (2008)

Evaluation of a Self-Administered Oral Glucose Tolerance Test
por: Bethel, M. Angelyn, et al.
Publicado: (2013)

Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
por: Baggio, Laurie L., et al.
Publicado: (2020)

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease
por: Stevens, Susanna R., et al.
Publicado: (2022)

Glycemic Index Versus Wheat Fiber on Arterial Wall Damage in Diabetes: A Randomized Controlled Trial
por: Jenkins, David J.A., et al.
Publicado: (2022)

Evaluation of the relationship between cardiac autonomic function and glucose variability and HOMA-IR in prediabetes
por: Dimova, Rumyana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fa7bv28qvndo6jsgipqcihhojb